Klinikum der Universität München (LMU Klinikum)

Case Report: Pediatric Renal Sarcoidosis and Prognostic Factors in Reviewed Cases (2021) Klaus R, Jansson AF, Griese M, Seeman T, Amann KU, Lange-Sperandio B Journal article The CAR-HEMATOTOX model identifies patients with a high risk for CAR T-cell related hematotoxicity and is associated with prolonged hospitalization and poor prognosis (2021) Rejeski K, Perez A, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, et al. Conference contribution Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma (2021) Rejeski K, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, Bucklein , et al. Conference contribution How does phagocytosis affect macrophages? (2021) Biedermann A, Flamann C, Mougiakakos D, Bitterer K, Leffler M, Kellner C, Peipp M, et al. Conference contribution Sirolimus in renal transplant recipients with malignancies in Germany (2021) Naik MG, Arns W, Budde K, Diekmann F, Eitner F, Gwinner W, Heyne N, et al. Journal article Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution Patient-oriented Comparison of Systemic Therapies for Patients with advanced Melanoma - A multicenter Cross-sectional Study (2021) Thiem A, Mashhadiakbar P, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, Heppt M, et al. Conference contribution Pädiatrische epileptische Enzephalopathien mit Manifestation oberhalb des Neugeborenenalters: ein Up-date (2021) Trollmann R, Borggräfe I, Müller-Felber W, Brandl U Journal article, Review article KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution A benchmark for neural network robustness in skin cancer classification (2021) Maron RC, Schlager JG, Haggenmüller S, von Kalle C, Utikal JS, Meier F, Gellrich FF, et al. Journal article